Murawski IJ, Myburgh DB, Favor J, Gupta IR. Vesico-ureteric reflux and urinary tract development in the Pax2 1Neuϩ/Ϫ mouse.
-Vesico-ureteric reflux (VUR) is a urinary tract abnormality that affects roughly one-third of patients with renal-coloboma syndrome, an autosomal dominant condition caused by a mutation in PAX2. Here, we report that a mouse model with an identical mutation, the Pax2 1Neuϩ/Ϫ mouse, has a 30% incidence of VUR. In VUR, urine flows retrogradely from the bladder to the ureter and is associated with urinary tract infections, hypertension, and renal failure. The propensity to reflux in the Pax2 1Neuϩ/Ϫ mouse is correlated with a shortened intravesical ureter that has lost its oblique angle of entry into the bladder wall compared with wild-type mice. Normally, the kidney and urinary tract develop from the ureteric bud, which grows from a predetermined position on the mesonephric duct. In Pax2 1Neuϩ/Ϫ mice, this position is shifted caudally while surrounding metanephric mesenchyme markers remain unaffected. Mutant offspring from crosses between Pax2 1Neuϩ/Ϫ and Hoxb7/GFP ϩ/Ϫ mice have delayed union of the ureter with the bladder and delayed separation of the ureter from the mesonephric duct. These events are not caused by a change in apoptosis within the developing urinary tract. Our results provide the first evidence that VUR may arise from a delay in urinary tract maturation and an explanation for the clinical observation that VUR resolves over time in some affected children. kidney development; urinary tract maturation; intravesical ureter; ureteric bud DURING KIDNEY AND URINARY tract development, reciprocal signaling between the mesonephric duct and the adjacent metanephric mesenchyme induces the formation of an epithelial structure known as the ureteric bud. The distal portion of the ureteric bud branches to form the kidney, while the proximal portion elongates to become the ureter. Initially, the mesonephric duct and ureter are connected via a segment of tissue known as the common nephric duct. Later in development, the common nephric duct undergoes apoptosis which permits the ureter to contact the urogenital sinus, the future bladder (1) . Extensive remodeling of the lower ureter then occurs such that it develops an independent site of entry into the muscular layer of the bladder known as the trigone (53) .
Many of the genes that regulate ureteric budding and branching are also important for ureter maturation. One such gene is Pax2, a paired-box transcription factor expressed in a wide variety of developing tissues and organs including the optic/ otic vesicles, meso/metanephric kidneys, the spinal cord, and the midbrain/hindbrain. Humans with heterozygous PAX2 mutations develop renal-coloboma syndrome (RCS), a rare autosomal dominant disorder in which affected individuals have optic nerve colobomas, hearing problems, kidney abnormalities, and vesico-ureteric reflux (VUR). During kidney and urinary tract development, Pax2 is expressed in the mesonephric duct, the ureteric bud, the ureter, and in mesenchymal condensates (29) . Pax2 homozygous mutant mice (Pax2 Ϫ/Ϫ ) lack kidneys, ureters, and genital tracts and have eye and ear defects. They die in the newborn period from renal failure (55) . In 1996, the Pax2 1Neuϩ/Ϫ mouse was discovered to carry an identical mutation as humans with RCS: a G base insertion in exon 2 resulting in a truncated, nonfunctional protein that lacks DNA-binding activity (18) . The kidney phenotype in the Pax2 1Neuϩ/Ϫ mouse includes small kidneys with increased ureteric bud apoptosis, decreased ureteric bud branching, and decreased nephron number (41) . Although patients with RCS have been reported to have urinary tract abnormalities including VUR, urinary tract development has thus far not been examined in the Pax2 1Neuϩ/Ϫ mouse. VUR is a congenital defect of the urinary tract caused by the abnormal insertion of the ureter into the bladder leading to the retrograde flow of urine from the bladder to the ureters (33) . It affects 0.1-1% of all children and is associated with recurrent urinary tract infections, hypertension, and renal failure (8) . The uretero-vesical junction is the anatomical connection between the ureter and the bladder. The junction, composed of the intravesical ureter, the portion of the ureter within the bladder wall, and the surrounding bladder mucosa, is compressed and pulled closed when the bladder fills to form a physiological valve. This prevents the retrograde flow of urine into the ureters (42) . Detailed descriptions of the uretero-vesical junction date back to 1903 when the oblique angle of ureteral entry into the bladder wall was first identified as an important component that prevents VUR (45) . In the 1960s, cystoscopies were frequently performed and showed that humans with VUR had shortened intravesical ureters and widely separated and dilated ureteral orifices (57) .
In humans, VUR is often associated with small dysplastic kidneys (24) . In 1975, Mackie and Stephens (31) examined autopsies from infants with duplex kidneys and ureters and observed a relationship between the position of the ureteral orifice within the bladder and the degree of renal hypo/dysplasia: the more displaced the ureteral orifice, the more severe the kidney malformation. This observation was the basis for the "Bud" theory in which they proposed that an abnormal site of ureteric budding leads to combined urinary tract and kidney defects.
They hypothesized that VUR, dysplastic kidneys, and laterally displaced ureteral orifices could all arise from a ureteric bud that develops from a more caudal location along the mesonephric duct. In addition, the mesenchyme adjacent to the caudally shifted ureteric bud would be incompetent to respond to inductive signals and result in a malformed kidney.
The Bud theory has prevailed in the literature for many years but has not been formally tested because of the paucity of genetic mouse models with both urinary tract and renal malformations. Here, we report that the Pax2 1Neuϩ/Ϫ mouse has a congenital urinary tract defect, VUR, in addition to its eye and renal malformations. We examined this model to determine whether the Pax2 1Neuϩ/Ϫ mouse has a caudally positioned ureteric bud and whether this outcome is associated with VUR and renal dysplasia.
MATERIALS AND METHODS

Pax2
1Neuϩ/Ϫ and Hoxb7/GFP ϩ/Ϫ mouse colonies. Heterozygous Pax2 1Neuϩ/Ϫ mice (18) were crossed to Hoxb7/GFP ϩ/Ϫ transgenic mice that express green fluorescent protein (GFP) throughout the mesonephric duct and its derivatives (51) . All mice were maintained on a CD1 background. Embryos were generated by performing timed 2-h early morning matings and genotyped by PCR from either tail-clip or head DNA using previously described primers for Pax2, GFP (12, 51) , and Sry (5Ј-CCTCATCGGAGGGCTAAAGT-3Ј) and (5Ј-TCATGGAACTGCTAGCTTCTG-3Ј). The visualization of a vaginal plug was recorded as embryonic day (E) 0. All embryos were staged using Theiler's criteria and crown-rump lengths were measured to confirm the age of the embryos. Embryos collected between E10 and E17 were dissected using fluorescent microscopy to image mesonephric duct, ureteric bud, ureter, and kidney development. Studies were performed in accordance with the rules and regulations of the Canadian Council of Animal Care (CCAC). Animal protocols were approved by the McGill University Health Centre Animal Care Committee (UACC) and Ethics Committee.
VUR and intravesical ureter lengths. Postnatal (P) day 1 mice were tested for VUR as described by needling the bladder and injecting methylene blue dye (61) . VUR was identified by the retrograde passage of methylene blue dye to the ureters. Planar surface area measurements (22) for each kidney were obtained using SPOT RT software (v4.0, Diagnostic Instruments). The kidneys attached to their ureters were fixed and embedded in paraffin. Serial transverse sections were obtained at 10-m thickness and stained with hematoxylin and eosin (Sigma). The length of the intravesical ureter was measured as described by injecting 1% fast green dye into the renal pelvis of each kidney using a microinjector (Microinjector IM 300, Narishige) (61). The dye was photographed moving through the ureters into the bladder and the distance between the bladder periphery and the site of dye exit was defined as the intravesical ureteral length and measured using SPOT RT. Bladders were cut to allow the dye to exit more freely.
Whole mount in situ hybridization. In situ hybridization was performed (58) on timed whole embryos that were partially eviscerated to ensure adequate probe penetration. A DIG-labeled UTP (Roche) c-Ret probe was used to visualize the mesonephric duct and the ureteric bud in E10.5 embryos. The position of the ureteric bud was determined by measuring the distance between the caudal edge of the mesonephric duct and the start of the ureteric bud (61) . In situ hybridization using Gdnf and Robo2 cDNA probes (20) was performed on E10.25 embryos. To compare gene expression in wild-type and Pax2 1Neuϩ/Ϫ embryos, whole mount images were taken and four measurements were obtained: the anterior limit of gene expression was compared with the midline of the hindlimb, the posterior limit of gene expression was compared with the caudal edge of the hindlimb, the anteriorposterior length of gene expression was measured, and the total area of gene expression was measured. These measurements were taken by one observer who was blinded to the genotype of the embryonic tissue.
Detection of apoptosis. Sagittal cryosections were obtained at 10-m thickness from timed E11 embryos generated from Pax2 1Neuϩ/Ϫ /Hoxb7/ GFP ϩ/Ϫ crosses. Sections were preblocked with 0.3% Triton X-100 and 10% horse serum in PBS in a humidified chamber. Immunostaining was performed as previously described using a rabbit polyclonal antibody to activated caspase-3 (1). Staining of dorsal root ganglia was used as a positive control for apoptosis.
Statistical analyses. Statistical analysis was performed using Chisquared test of two proportions or Student's t-test. Statistical significance was set at a P value Ͻ0.05.
RESULTS
Pax2
1Neuϩ/Ϫ mice have VUR, dilated ureters, and duplicated urinary tracts. Mice were tested for VUR by injecting methylene blue into the bladder and observing whether the dye refluxed up the ureter. At P1, only 6.25% (n ϭ 48) of wild-type mice had VUR compared with 31.4% (n ϭ 51) of Pax2 mice; however, left-sided VUR was more frequently seen (P Ͻ 0.05; Fig. 1F ), consistent with at least one report in children (35) . Infants affected with VUR are more likely to be male, while in older children, there is a slight female predominance (23, 50) . Among the mutant mice, 45% of the males had VUR compared with only 12% of the females (P Ͻ 0.05). Transverse sections from paraffin-embedded tissues at the level of the kidney demonstrated that refluxing Pax2 1Neuϩ/Ϫ ureters were dilated compared with littermate controls (Fig. 1, D 
-E).
The smooth muscle layer was intact in mutant embryos and there were no gross malformations of any of the ureteral layers. In addition to hydroureters, bifid ureters and duplicated urinary tracts were observed in 27.6% of mutant mice between E11 and E17 and occasionally at P1 (Fig. 1 , G-I), as reported in humans with VUR (9) . Interestingly, in one mouse with a duplicated urinary tract, VUR was present in both ureters extending to the upper and lower pole of the duplex kidney. Pax2 1Neuϩ/Ϫ mice were crossed to Hoxb7/GFP ϩ/Ϫ mice to obtain offspring in which the ureteric bud and its derivatives were labeled by GFP. Kidneys in the mutant offspring had markedly reduced branching compared with their wild-type counterparts ( 
-test).
Pax2 1Neuϩ/Ϫ mice have short intravesical ureters that correlate with kidney size. The length of the intravesical ureter, the portion of the ureter within the bladder wall, was measured in wild-type and Pax2 1Neuϩ/Ϫ mice by injecting 1% fast green dye into the renal pelvis and observing its exit from the ureteral orifice. At P1, Pax2 1Neuϩ/Ϫ mice had significantly shorter left (P Ͻ 0.05, Student's t-test) and right (P Ͻ 0.05, Student's t-test) intravesical ureters than their wild-type littermates (Fig. 2) . Mean lengths of the intravesical ureter Ϯ SE in the mutant mice were 0.261 Ϯ 0.013 mm, n ϭ 16 (left ureter) and 0.256 Ϯ 0.022 mm, n ϭ 9 (right ureter), and of the wild-type mice were 0.351 Ϯ 0.01 mm, n ϭ 21 (left ureter) and 0.348 Ϯ 0.013 mm, n ϭ 15 (right ureter). Both the kidney and the ureter develop from the ureteric bud, so we determined whether there was a relationship between kidney size and intravesical ureter length. In Pax2 1Neuϩ/Ϫ mice, mean kidney planar surface area Ϯ SE positively correlated with intravesical ureter length (y ϭ 0.02x ϩ 0.16, R 2 ϭ 0.4, P Ͻ 0.05, 4.324 Ϯ 0.314 mm 2 , n ϭ 20), while in wild-type mice, there was no relationship, likely because they had very little variation in kidney size (y ϭ 0.006x ϩ 0.305, R 2 ϭ 0.05, P Ͼ 0.05, 5.918 Ϯ 0.131 mm 2 , n ϭ 32). We also examined whether refluxing Pax2 1Neuϩ/Ϫ mice had smaller kidneys than their nonrefluxing mutant littermates, but we were unable to show a correlation (P Ͼ 0.05, data not shown). This may have been due to variability in the Pax2 1Neuϩ/Ϫ kidney phenotype due to haploinsufficiency (47) and/or the possibility that additional factors predispose to VUR. Pax2 1Neuϩ/Ϫ mice have more caudally positioned ureteric buds. An altered position of ureteric budding has been postulated to cause maldevelopment of both the kidney and the urinary tract (31) . To determine whether the renal dysplasia and VUR observed in the Pax2 1Neuϩ/Ϫ mouse were due to an abnormality in the site of ureteric budding, we used whole mount in situ hybridization to detect Ret transcripts within the mesonephric duct and the emerging ureteric bud. At E10.5, the ureteric bud was visible as an outgrowth extending dorsally from the mesonephric duct. The distance from the end of the mesonephric duct to the edge of the ureteric bud was determined to be significantly shorter in Pax2 1Neuϩ/Ϫ mice compared with wild-type littermates, consistent with a more caudally positioned ureteric bud (P Ͻ 0.05, Student's t-test; Fig. 3 ). Mean lengths of the distance from the end of the mesonephric duct to the ureteric bud Ϯ SE in the Pax2 1Neuϩ/Ϫ mice were left: 0.095 Ϯ 0.003 mm, n ϭ 15 and right: 0.099 Ϯ 0.005 mm, n ϭ 15 compared with left: 0.142 Ϯ 0.008 mm, n ϭ 10 and right: 0.149 Ϯ 0.010 mm, n ϭ 10 in the wild-type mice.
Pax2 1Neuϩ/Ϫ mice do not exhibit altered Gdnf or Robo2 gene expression. Genes expressed by the mesonephric duct and the adjacent mesenchyme regulate the emergence of the ureteric bud. Loss of genes, such as Slit2 and Robo2, result in multiple ureteric buds and an expanded domain of Gdnf expression (20) . Since Gdnf is expressed in the metanephric mesenchyme and both an important mediator of ureteric bud development and a 1Neuϩ/Ϫ kidneys are smaller and bilateral VUR (arrows) is seen extending to the renal pelvis. C: graphical representation of the incidence of VUR in wild-type (6.25%) and Pax2 1Neuϩ/Ϫ mice (31.37%). D and E: kidneys and ureters from newborn mice were paraffin-embedded and transverse sections were obtained through the ureter at the level of the kidney (magnification ϫ200). D: transverse section of the ureter at the level of the kidney shows a wild-type ureter has a normal transitional epithelium surrounded by smooth muscle layers (arrow). E: Pax2 1Neuϩ/Ϫ ureter is dilated, but histologically normal (arrow; magnification ϫ200 PAX2 target (7), we tested whether the caudally positioned ureteric bud in Pax2 1Neuϩ/Ϫ mice was associated with a shift in Gdnf gene expression. Recent publications examined the domain of Gdnf by in situ hybridization and described its expression relative to the position of the hindlimb (20) . We obtained measurements of the anterior and posterior limits of gene expression, the total length of gene expression, and the total area of gene expression. Although some mutant embryos appeared to have smaller domains of Gdnf expression, no significant differences were noted between them and wild-type embryos (P Ͼ 0.05, Student's t-test; Fig. 4 and Table 1 ). Robo2 is a second metanephric mesenchyme marker whose loss leads to an expanded domain of Gdnf expression and supernumerary ureteric buds (20) . No differences in Robo2 expression were able to account for the caudally positioned ureteric buds or the duplex urinary tracts observed in Pax2 1Neuϩ/Ϫ embryos (P Ͼ 0.05, Student's t-test; Fig. 4 and Table 1 ). Bmp4 expression was also examined and no gross changes were noted (data not shown).
Pax2 1Neuϩ/Ϫ mice exhibit a delay in ureter maturation but this is not due to a difference in common nephric duct apoptosis. We determined whether the altered site of ureteric budding was due to a delay in development of the urinary tract.
Pax2
1Neuϩ/Ϫ mice were crossed with Hoxb7/GFP ϩ/Ϫ mice to visualize the developing kidney and urinary tract (Fig. 5A) . No differences were observed in the mesonephric duct of wildtype and mutant mice before E10. At E10, a slight swelling of the posterior region of the mesonephric duct, the site of the future ureteric bud, was apparent in both Pax2 1Neuϩ/Ϫ (n ϭ 14) and wild-type (n ϭ 7) embryos. GFP was used as a marker to follow the emergence of the ureteric bud at E10.25 using the same methodology as in Fig. 3 : Pax2 1Neuϩ/Ϫ embryos had more caudally positioned ureteric buds and some buds had irregular contours compared with their wild-type counterparts (n ϭ
1Neuϩ/Ϫ ureters (P Ͻ 0.05, Chi-squared ϭ 8.57). The delay in ureter separation from the mesonephric duct was even more apparent at E14: 25% (6/24) of Pax2 1Neuϩ/Ϫ ureters remained attached to the mesonephric duct compared with 6.25% (2/32) of wild-type ureters (P Ͻ 0.05, Chi-squared ϭ 3.94). At E17, all Pax2 1Neuϩ/Ϫ ureters had independent openings into the bladder, but their entry was at a less oblique angle compared with wild-type ureters. An oblique angle of entry was defined as a ureter that had a curved entry into the bladder. Sixty-nine percent (9/13) of wild-type embryos had ureters that entered the bladder at an oblique angle compared with only 18% (2/11) of mutant embryos (P Ͻ 0.05, Chi-squared ϭ 6.25). We compared the crown-rump lengths of Pax2 1Neuϩ/Ϫ and wild-type mice at these same embryonic stages to determine whether a global delay in somatic growth was responsible for the delay in kidney and ureter development. No differences in crown-rump lengths were observed between Pax2 1Neuϩ/Ϫ and wild-type embryos (P Ͼ 0.05; Table 2 ), suggesting that the observed delay was urinary tract specific.
Apoptosis in the common nephric duct is involved in the separation of the ureter from the mesonephric duct (1). To investigate whether a change in apoptosis was responsible for the delay in urinary tract development, sections were obtained at the level of the common nephric duct at E11, before the onset of the delay. We observed similar levels of activated caspase-3 protein in both wild-type and Pax2 1Neuϩ/Ϫ embryos (Fig. 5, B-D) , and the majority of the signal was detected within the lumen of the common nephric duct, the mesonephric duct, and the ureter. The delay in urinary tract development was thus not due to a change in apoptosis in the common nephric duct or the surrounding tissues.
DISCUSSION
We identified a new mouse model of VUR, the Pax2 1Neuϩ/Ϫ mouse, which directly parallels a human disorder, RCS. Approximately 26% of RCS patients develop VUR in addition to optic colobomas and kidney malformations (16) . Our results suggest that the urinary tract defect arises early during embryogenesis from an alteration in the site of ureteric budding that is followed by a delay in ureter development. These events lead to a shortened intravesical ureter that has lost its oblique angle of entry into the bladder, predisposing affected mice to VUR.
Using the Pax2
1Neuϩ/Ϫ mouse to understand urinary tract development and VUR. The Bud theory proposes that a caudal ureteric bud results in a refluxing ureter (31) . Such positioning of the ureteric bud would lead to a shortened common nephric duct, resulting in the early union of the ureter with the urogenital sinus, accelerated separation of the ureter from the mesonephric duct, and lateral displacement of the ureter within the bladder wall (30, 59) . The mesenchyme adjacent to the abnormally positioned ureteric bud would be incompetent to respond to inductive signals, resulting in malformed kidneys. While this theory fails to account for all of the features of the refluxing urinary tract, it presents a hypothesis to explain the clinical association of VUR with small or malformed kidneys (34) .
VUR spontaneously disappears in as many as 71% of affected children, indicating that this condition can resolve over time (17) . This observation supports an alternative theory that VUR is due to a delay in ureter development. In children in which the condition resolves, it is presumed that the ureter has grown and formed a more competent uretero-vesical junction (26) . We observed that Pax2 1Neuϩ/Ϫ embryos had more caudal ureteric buds, and by E12.25, they showed a delay in ureter maturation. These findings suggest that aspects of both theories may be true.
To characterize the delay in urinary tract development, we examined the onset of ureteric bud formation between E10 and E11. At E10, the mesonephric duct begins to swell and a single ureteric bud emerges by E10. 25 . No differences between wildtype and mutant mice were observed in the timing of the onset of mesonephric duct swelling, the emergence of the ureteric bud, or the first ureteric bud bifurcation. Thus the ureteric bud forms de novo from a predetermined location along the duct and does not migrate along the duct to reach its final location. In the Pax2 1Neuϩ/Ϫ mouse, the caudal ureteric bud arises from a physical displacement in the position of budding and is not due to a delay in ureteric bud formation. This is likely the initial event that leads to the urinary tract malformation. Although bifid and duplicated ureters were observed, double ureteric buds were never seen, suggesting that the duplicated urinary tracts arose after formation of the ureteric bud. The Bud theory proposes that the cranial or rostral ureter in a duplicated urinary system will be obstructed. We rarely observed complete duplications in the newborn period, therefore we were unable to test this aspect of the theory. When dupli- cated systems were tested for reflux in the newborn period, there were cases in which both ureters freely refluxed suggesting no obstruction at the level of the uretero-vesical junction in those mice.
To investigate the molecular basis for a caudally positioned ureteric bud, we examined gene expression during its formation. The ligand GDNF is secreted from the surrounding metanephric mesenchyme and interacts with RET, a receptor tyrosine kinase, and GFR␣1, a coreceptor, both of which are expressed by the ureteric bud. This signaling event initiates the emergence of the ureteric bud from the mesonephric duct (44) . Gdnf is a known target of PAX2 (7), and a shift in the domain of Gdnf expression has been associated with the emergence of ectopic ureteric buds in a number of mutant mice (20, 28) . Although no abnormality was noted in the Gdnf expression pattern of Pax2 1Neuϩ/Ϫ embryos, we cannot exclude the possibility that there may be important quantitative differences in expression between wild-type and mutant embryos. The expression of Gdnf in the mesenchyme is in the shape of a teardrop which may represent an increasing concentration gradient along the anterior-posterior axis (15) . Therefore, a 50% reduction of GDNF in Pax2 1Neuϩ/Ϫ embryos could lead to a more caudally positioned ureteric bud as the bottom edge of the teardrop would be relatively more abundant in GDNF.
Both Pax2 and another one of its targets, Ret, are critical for ureteric bud development as homozygous mutants for either gene fail to form ureteric buds (7, 49) . In addition, kidneys from Pax2 ϩ/Ϫ mice have been shown to have reduced Ret expression by quantitative RT-PCR (13) . Our work suggests that alterations in the domain of Ret expression are also important for the position of ureteric budding. As shown in Fig.  3 , Ret transcripts are detected in the mesonephric duct and the ureteric bud in both wild-type and Pax2 1Neuϩ/Ϫ mice. How- Fig. 5 . Pax2 1Neuϩ/Ϫ mice exhibit a delay in ureter maturation but this is not due to a difference in common nephric duct apoptosis. A: Pax2 1Neuϩ/Ϫ mice were crossed with Hoxb7/GFP ϩ/Ϫ mice and embryos were dissected at various stages to visualize kidney and urinary tract development. E10: similar swelling of the posterior end of the mesonephric duct is apparent in both Pax2 1Neuϩ/Ϫ and wild-type embryos. E10.25: more caudal ureteric bud is seen emerging from Pax2 1Neuϩ/Ϫ mesonephric ducts. E11.25: ureteric bud has bifurcated once and the common nephric duct (arrow) is seen connecting the ureter and the mesonephric duct. No differences in the length of the common nephric duct were observed. E12.25: wild-type ureters are beginning to separate from their corresponding mesonephric ducts (arrow) while Pax2 1Neuϩ/Ϫ ureters appear delayed and remain attached to the mesonephric duct (arrowhead). E14: wild-type ureter is seen with an independent opening into the bladder (arrow) while the mutant ureter remains attached to the mesonephric duct (arrowhead). E17: wild-type embryos have ureters that insert into the bladder wall at an oblique angle (arrow) while Pax2 1Neuϩ/Ϫ embryos have ureters that enter less obliquely (arrowhead).
B-D: Pax2
1Neuϩ/Ϫ mice were crossed with Hoxb7/GFP ϩ/Ϫ mice and embryos were dissected at E11 and used for apoptosis assays. B: activated caspase-3 protein was detected within the lumen of the common nephric duct (outlined by inset), the mesonephric duct, and the ureter of both wild-type and mutant (B) embryos (magnification ϫ200). The common nephric duct is shown for wild-type (C) and Pax2 1Neuϩ/Ϫ (D) embryos. The epithelial layer (*) is labeled with DAPI (blue) and surrounds the lumen (arrow) which exhibits numerous cells undergoing apoptosis (red). Similar levels of apoptosis were observed in both wild-type and Pax2 1Neuϩ/Ϫ embryos. cnd, Common nephric duct; us, urogenital sinus; sv, seminal vesicle. ever, the site of ureteric budding as marked by Ret is caudally shifted in the mutant mice compared with the wild-type mice.
From these results, we cannot address whether the alteration in Ret expression is the primary event that leads to the caudally shifted ureteric bud or whether the ureteric bud is caudally shifted and secondarily the domain of Ret expression is altered.
In a different mouse model in which Ret is overexpressed as a transgene driven by the Hoxb7 promoter, we also noted that the position of the ureteric bud was caudally shifted (61) . Taken together, these two models suggest that the domain of Ret expression is critical to the site of ureteric budding. In the Pax2 1Neuϩ/Ϫ mouse, we propose that either the decreased amount of PAX2 or its effect on target genes, such as Gdnf, Ret, and Gata3, contributes to the caudally shifted ureteric bud.
In addition to genes that promote the emergence of the ureteric bud, there are genes that are inhibitory. In mouse models, the loss of inhibitors leads to an expanded domain of Gdnf expression and supernumerary ureteric buds (20, 28) . We examined the repressor Robo2, however, no gross differences in its expression were able to account for the caudally positioned ureteric buds or the duplex urinary tracts observed in Pax2 1Neuϩ/Ϫ embryos. BMP4 is a growth factor known to inhibit ectopic ureteric budding (36) . Although an alteration in Bmp4 expression could have contributed to the caudally shifted ureteric buds, its diffuse expression throughout the mesenchyme adjacent to the mesonephric duct made it difficult to discern a clear domain of expression for comparative analysis by whole mount in situ hybridization. We analyzed two markers of the metanephric mesenchyme, Robo2 and Gdnf, and found that the metanephric mesenchyme was normally located in mutant embryos. We speculate that the kidney and urinary tract defects in the Pax2 1Neuϩ/Ϫ mouse are initiated when the caudally shifted ureteric bud contacts the lower end of the metanephric mesenchyme that is not able to sustain normal kidney or urinary tract development due to a change in the local environment of growth factors and transcription factors.
Beginning at E12. 25 , there was a quarter of a day delay, and by E14, there was a day and a half delay in Pax2 1Neuϩ/Ϫ urinary tract maturation such that the ureters did not separate as rapidly from the mesonephric ducts. Although we cannot track the growth of a single ureteric bud as it lengthens into a ureter in vivo, our data demonstrate that the caudal ureteric bud arises before the onset of the delay in mutant embryos. A delay in urinary tract maturation was observed in all mutant embryos. However, the extent of the delay was variable, therefore it was not surprising that only 31% of the mutant mice had VUR. Phenotypic variability in the extent of the delay and its impact on the competence of the uretero-vesical junction at P1 were likely caused by PAX2 haploinsufficiency and/or because the mice were bred on an outbred CD1 background (47, 48) .
Normally at E11, the common nephric duct undergoes apoptosis to allow the ureter to separate from the mesonephric duct (1). We examined embryos at E11 to determine whether a change in common nephric duct apoptosis was mediating the urinary tract delay. Although no differences were noted, this may not have been completely unexpected. First, the Pax2 1Neuϩ/Ϫ mouse has intact ureters and uretero-vesical junctions, therefore a major change in apoptosis is unlikely. Second, the role of PAX2 in cell survival may not be of primary importance in the developing urinary tract as reported in the kidney (3, 32): its functions in cellular differentiation and tissue remodeling may be more critical. Taken together, the most plausible explanation for the urinary tract defect is that there is a combination of a physical displacement in the position of ureteric budding and a developmental delay. Fig. 6 . Current and revised model of caudal ureteric budding from the mesonephric duct. A-C: from left to right the images depict 2 lateral and 2 posterior views, respectively. A: normally positioned ureteric bud (orange) emerges from the mesonephric duct (blue). The distal end branches to form the collecting ducts of the kidney while the proximal end forms the ureter. Vertical displacement of the ureter leads to separation of the ureter from the mesonephric duct within the urogenital sinus (yellow). Once the ureter has achieved an independent opening into the bladder, the length of the intravesical ureter and its angle of entry into the bladder wall prevent against VUR. B: old model of ureteric budding predicts that a caudal ureteric bud will cause early separation of the ureter from the mesonephric duct and increased lateral migration of the ureter within the bladder wall. This is believed to result in an abnormally positioned ureteral orifice and a short intravesical ureter that refluxes. However, our data do not support this model. C: our revised model of ureteric budding shows that a caudal ureteric bud leads to delayed union of the ureter with the urogenital sinus and delayed separation of the ureter from the mesonephric duct. These events lead to the development of a shorter intravesical ureter that has lost its oblique angle of entry into the bladder and a refluxing ureter. D: ureteral insertion is likely influenced by bladder development as originally suggested by Frazer (19) . As the bladder grows (steps 1-3) , the intravesical ureter lengthens and enters the bladder wall at an oblique angle (step 3). Delayed separation of the ureter from the mesonephric duct could impair ureteral maturation and bladder growth such that the intravesical ureter resembles that shown in step 2. This ureter has a shorter intravesical segment and a less oblique angle of entry that predisposes to VUR. E: in 2 VUR mouse models, the Hoxb7/Ret ϩ/Ϫ and the Pax2 1Neuϩ/Ϫ mouse, we found the ureteric bud is shifted by ϳ40% (green line) compared with wild-type littermates (red line). F: at birth, the intravesical ureter is shortened by ϳ20% in these 2 refluxing mouse strains compared with wild-type mice.
Pax2 targets and their roles in urinary tract development.
True haploinsufficiency is rare and usually occurs when the protein of interest must interact or compete with other gene products as part of a developmental switch or complex pathway (47) . In Pax2 1Neuϩ/Ϫ mice, kidney and urinary tract development is sensitive to gene dosage: a 50% reduction in the amount of PAX2 protein results in a shifted ureteric bud, a decrease in ureteric bud branching, and a delay in ureter maturation.
While a number of genes regulated by PAX2 are functionally important in the developing kidney, their roles in the urinary tract are not as well-defined (2, 6, 13, 14, 21, 54) . In Xenopus laevis, PAX2 acts with WNT4 and WT1, and the transcription factor LIM1 to guide pronephric duct elongation (10) . Gata3 is a target of both PAX2 and PAX8 (21) and is involved in guidance of the pronephric duct toward the cloaca. In humans, GATA3 mutations cause renal anomalies and VUR as part of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome (56) . Eya1, Six1, Foxc1, and Foxc2 are a group of transcription factors that regulate Gdnf (4, 28, 60) . A Pax/Six/Eya gene network regulates ureteric bud development (5) and mutations in the network are associated with familial renal and urinary tract malformations. Patients with branchiooto-renal (BOR) syndrome have heterozygous mutations in either EYA1 and SIX1 and can develop urinary tract defects including VUR (43) .
The evidence above suggests that many of the guidance and/or directional cues that are necessary for pronephric and mesonephric duct development are also important for the steps of ureter maturation. Because the Pax2 1Neuϩ/Ϫ mouse is haploinsufficient, it is difficult to demonstrate differences in gene expression using qualitative methods like in situ hybridization to explain the caudal emergence of the ureteric bud or the delay in urinary tract maturation. However, we speculate that important quantitative differences in either targets of Pax2 or genes within the Pax/Six/Eya network are most likely responsible for the urinary tract defects we observe. Future work will need to identify the specific targets of Pax2 and its regulatory networks within the developing urinary tract.
Genetics of VUR and mouse models. VUR most frequently occurs as primary VUR, in which there is an isolated urinary tract malformation with or without a kidney defect. It can also present as syndromic VUR, in which there are other system defects as in RCS, HDR, or BOR. Studies of primary VUR in multigenerational families demonstrate that the condition is genetically heterogeneous (46) . Thus far, RCS-causing mutations have all been identified at the 5Ј-end of the PAX2 gene. Although one family study failed to identify PAX2 mutations in primary VUR (11) , it is possible that mutations or polymorphisms at the 3Ј-end that affect the transactivation potential of PAX2 are associated with this condition (38, 47) .
Based on the five mouse models of VUR thus far described (25, 27, 39, 40, 61) , genes expressed in the mesonephric duct, the ureteric bud, or surrounding metanephric mesenchyme are all potential candidates to consider in human studies of primary VUR. Deletion of the mesenchymally expressed Agtr2 gene leads to urinary tract duplications, VUR, and double ureteric buds. Mice lacking UpkII or UpkIII, genes that are expressed by the uroepithelium, have VUR, although it is as yet unknown whether this is due to a defect during urinary tract formation.
Lim1
Ϫ/Ϫ conditional knockout mice have VUR and defects in mesonephric duct elongation, but abnormalities in the position of ureteric budding have not been reported. In addition to malformed kidneys (52), our laboratory identified that overexpression of Ret in the Hoxb7/Ret ϩ/Ϫ mouse leads to VUR (61) . Importantly, both the Hoxb7/Ret ϩ/Ϫ mouse and the Pax2 1Neuϩ/Ϫ mouse have ureteric buds that are ϳ37% closer to the end of the mesonephric duct and intravesical ureters that are ϳ20% shorter. These two models therefore suggest that VUR with renal malformation in humans is a developmental field defect that originates from a single caudally shifted ureteric bud (37) . These results have implications in the clinical care of patients with VUR in that the malformed urinary tract may be accompanied by severe or subtle defects in nephrogenesis.
Model and conclusions. Our model of the relationship between the position of ureteric budding along the mesonephric duct and the development of urinary tract defects differs from the original Bud theory (Fig. 6 ). As proposed, we find that the ureteric bud in Pax2 1Neuϩ/Ϫ mice exits from a more caudal location along the mesonephric duct and is likely the initial step responsible for the combined kidney and urinary tract defects. However, in contrast to this theory, our results suggest that this event is subsequently followed by a significant delay in the separation of the ureter from the mesonephric duct. This delay results in a shorter intravesical ureter that has lost its oblique angle of entry into the bladder leading to an incompetent uretero-vesical junction that refluxes. The steps by which the intravesical ureter tunnels through the bladder wall are not well-described. Tunneling may begin once the ureter has completely separated from the mesonephric duct. If true, then slower separation of the ureter from the duct could reduce the length of time for ureteral growth into the bladder. Growth of the bladder around the separating ureter also needs to be considered as this may affect ureteral migration within the bladder wall as originally proposed by Frazer (19) . These questions will be better answered once there are means to fluorescently label the developing trigone in relation to the intravesical ureter.
